Splicing regulatory dynamics for precision analysis and treatment of heterogeneous leukemias
- 7 May 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (797) , eadr1471
Abstract
The role of splicing dysregulation in cancer is underscored by splicing factor mutations; however, its impact in the absence of such rare mutations remains poorly understood. Prompted by the finding that splicing uniquely resolved genetic subtypes of cancer, we developed an unsupervised computational workflow called OncoSplice to comprehensively define tumor molecular landscapes. In adult and pediatric acute myeloid leukemia (AML), OncoSplice identified the spectrum of driver genetics from splicing profiles alone, defined more than a dozen previously unreported molecular subtypes recurrent across AML cohorts, and discovered a dominant splicing subtype that partially phenocopies U2AF1 -mutant splicing. Although pediatric leukemias lack splicing factor mutations, this U2AF1 -like subtype similarly spanned pediatric and adult AML genetics and consistently predicted poor prognosis. Using long-read single-cell RNA sequencing, we confirmed that discovered U2AF1 -like splicing was shared across cell states, co-opted a healthy circadian gene program, was stable through relapse, and induced a leukemic stem cell program. Pharmacological inhibition of an implicated U2AF1 -like splicing regulator, PRMT5, rescued leukemia missplicing and inhibited leukemic cell growth. Finally, genetic deletion of IRAK4 , a common target of U2AF1 -like and PRMT5 treatment, blocked leukemia development in xenograft models and induced differentiation. This work suggests that broad splicing dysregulation, in the absence of select mutations, is a therapeutic target in heterogeneous leukemias.Keywords
All Related Versions
This publication has 80 references indexed in Scilit:
- Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic RasCell, 2017
- U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3′ End FormationMolecular Cell, 2016
- Characterization of the expression of the pro-metastatic MenaINV isoform during breast tumor progressionClinical & Experimental Metastasis, 2015
- Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch PointCell Reports, 2015
- SRSF1-Regulated Alternative Splicing in Breast CancerMolecular Cell, 2015
- SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon RecognitionCancer Cell, 2015
- Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In VivoCancer Cell, 2015
- TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD− mutationsInternational Journal of Hematology, 2014
- Multidrug resistant Vibrio cholerae O1 El Tor carrying classical ctxB allele involved in a cholera outbreak in South Western IndiaActa Tropica, 2011
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010